Просмотр всех статей в Новости фондового рынка и Торговые идеи
2014

Сен
15

SPY отыграл гэп вниз на премаркете

Ближайший уровень поддержки по SPY – 198.60 уровень сопротивления – 199.10

analytics-15-09-2014

AVB покупка от 145

SLG покупка выше 104

VNG смотрим на покупку

Gapping up/down: TWGP +12% on M&A approval, spirit related names also higher on M&A spec in the space, NOK +2% on upgrade; TEX -8% after guidance, RAX -4% after dg

Gapping up
M&A news: TWGP +11.7% (ACP Re announced that ACP Re has received all regulatory approvals required in connection with its previously announced acquisition of Tower), CTSH +2.8% (to acquire TriZetto for $2.7 bln in cash), WHR +2.1% (receives written approval from the China Securities Regulatory Commission to acquire a 51% stake in Hefei Rongshida Sanyo Electric), VC +1.1% (may be a possible takeover target, Bloomberg real M&A column says)

Other news: RSH +17.6% (considering $585 mln financing package, also Hearing Suntrust analyst suggesting reasoning behind potential Amazon (AMZN) deal), OTIV +13.2% (extending last weeks gains), TAP +7.2% (in response to M&A stories in the space), HALO +5.9% (partner Baxter (BAX) receives FDA approval from HYQVIA for treatment of adults with primary immunodeficiency), AU +5.5% (Hearing speculation that company will not proceed with restructuring), BPOP +3.8% (positive Barrons mention), ATHM +3.6% (favorable commentary on Friday’s Mad Money, Tiger Global Management discloses 18.5% passive stake), BUD +3.1% (in financing talks for SABMiller deal), MYL +2.5% (Mylan Labs signs agreement with Gilead (GILD) to accelerate access to hepatitis C treatments), BITA +2.5% (Tiger Global Management discloses 14.9% passive stake), TGTX +2.5% (announces special protocol assessment agreement with the FDA for its first phase 3 clinical trial of TG-1101), DEO +2.2% (in response to M&A stories in the space), TASR +2% (Columbus and Knoxville join major cities moving to AXON cameras and EVIDENCE.com; new body-worn camera programs launch in Argentina and United Arab Emirates), YHOO +1.8% (Alibaba (BABA) may increase IPO range amid high demand to above $70 from $60-66 prior, according to reports), MO +1.8% (co has a 26.9% voting interest in Sabmiller (SBMRY))

Analyst comments: WGO +5.2% (initiated with an Outperform at BMO Capital Mkts), PAY +1.8% (initiated with a Buy at Monness Crespi & Hardt), NOK +1.7% (upgraded to Outperform at Oppenheimer), AYI +1.6% (upgraded to Buy from Neutral at Goldman), ABX +0.9% (upgraded to Neutral from Underweight at HSBC Securities)

Gapping down
In reaction to disappointing earnings/guidance: TEX -7.8%

Select oil/gas related names showing early weakness: E -1.2%, SDRL -1%, TOT -1%, BP -0.7%

Other news: NPSP -14.0% (FDA Advisory Committee votes 8-5 the recommend approval of Natpara), NETE -7% (pulling back following Friday’s advance), ACHN -3% (still checking), INSY -2.9% (disclosed it received a subpoena requesting documents regarding Subsys), ALXN -1.8% (reports 5 yr results of Asfotase Alfa in ped patients with severe HPP), WB -1.5% (still checking), BHP -0.8% (weak industrial production figures out of China), DE -0.6% (in sympathy with TEX), CAT -0.5% (in sympathy with TEX)

Analyst comments: RAX -3.9% (downgraded to Neutral from Overweight at JP Morgan), TSLA -2.2% (weakness attributed to Morgan Stanley analyst comments, suggesting stock may be a bit ahead of itself), PKD -1.6% (downgraded to Equal Weight from Overweight at a boutique firm), PLOW -1.2% (downgraded to Neutral from Outperform at Robert W. Baird), UBS -1.2% (downgraded to Equal Weight from Overweight at Barclays), TRP -1% (downgraded to Sell from Neutral at Goldman), CLW -0.7% (downgraded to Neutral at DA Davidson)

2014

Сен
12

SPY слегка снижается

Ближайший уровень поддержки по SPY – 200.00 уровень сопротивления – 200.40

analytics-12-09-2014

LULU проада от 44

LE продажа ниже 45

WB продажа от 25

VSI продажа от 44

DATA продажа от 76.50

VNET покупка от 16

Gapping up/down: ULTA +16% and DRI +3.5% after earnings, CNVR +32% after merger with ADS +2.4%, NFLX +0.7% after upgrade; CHKE -8% after earnings

Gapping up
In reaction to strong earnings/guidance: ULTA +16.1%, CGA +8.3%, SPWH +7.6%, CVTI +7.6%, DRI +3.5%, NTWK +3%

M&A news: CNVR +32.6% (Alliance Data to acquire Conversant), ADS +2.4%

Other news: ASTI +11.5% (regains compliance with NASDAQ minimum bid price rule), STRI +11.5% (still checking), XPO +8.7% (announced a $700 mln investment by PSP Investments, GIC, Singapore’s sovereign wealth fund, and Ontario Teachers’ Pension Plan; co also raised its FY17 financial targets), LXRX +8.4% (announced a publication in the American Diabetes Association’s Journal), ACAD +4.8% (favorable commentary on Thursday’s Mad Money), FUEL +4.4% (following late spike into the close), HTZ +4.2% (Hertz Global reaches an agreement-in-principle with Carl Icahn to add Three Directors), VNET +4% (cont volatility), RMTI +3.9% (still checking), CRTO +3.7% (following late move higher), BTX +3.7% (co’s subsidiary reached an agreement with Cancer Research UK and Cancer Research Technology for a clinical trial of immunotherapy vaccine for lung cancer), TASR +2.9% (favorable commentary on Thursday’s Mad Money), ISIS +2.7% (favorable commentary on Thursday’s Mad Money), SCOK +2.5% (following 18% move higher yesterday), OREX +2.3% (mentioned positive on CNBC’s Fast Money), NVO +2.1% ( FDA’s Endocrinologic and Metabolic Drugs Advisory Committee votes 14-1 in favor of recommending approval of liraglutide for chronic weight management ), BCS +2.1% (John McFarlane appointed to succeed Sir David Walker as Chairman), WWAV +1.8% (cont M&A spec), TNET +1.6% (prices 12 mln shares of common stock at a price of $25.50 per share ), S +1.5% (announces exclusive new rate plan for iPhone 6 and iPhone 6 plus and a revolutionary new way to acquire iPhone, also upgraded to Outperform from Mkt Perform at Cowen), FEYE +1.1% (cont volatility), HDS +1% (announces sale of 20,000,000 shares of common stock by selling stockholders)

Analyst comments: NLNK +4.9% (initiated with a Buy at Mizuho), TMUS +1% (upgraded to Buy from Hold at Argus), IRC +0.9% (upgraded to Buy from Hold at KeyBanc Capital Mkts), NFLX +0.7% (upgraded to Equal Weight from Underweight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: CHKE -7.9%

Select metals/mining stocks trading lower: GFI -2.5%, HMY -1.1%, GOLD -1%, IAG -0.5%.

Other news: ACHN -3.3% (negative commentary on Thursday’s Mad Money), HCN -3.1% (announces proposed offering of 15,500,000 shares of common stock), SDRL -2.8% (still checking), PPL -1.9% (Federal Appeals Court sides with PPL, affirms New Jersey Court decision invalidating state legislation subsidizing new power plants), AMAT -1.4% (unfavorable China’s Ministry of Commerce determination in Tokyo Electron deal), KATE -1.1% (negative commentary on Thursday’s Mad Money)

Analyst comments: RKUS -4.5% (initiated with a Underweight at Morgan Stanley), DDR -3.5% (downgraded to Hold from Buy at KeyBanc Capital Mkts, downgraded to Neutral from Buy at UBS)

2014

Сен
11

SPY падает на премаркете

Ближайший уровень поддержки по SPY – 199.00 уровень сопротивления – 199.70

analytics-11-09-2014

LE продажа от 40

EMES покупка выше 130

SLCA покупка выше 70

UTHR продажа от 122

GPRO покупка выше 69

Gapping up/down: JDSU +14% after guidance/spin-off announcement, LULU +14% after earnings, GPRO +3% after gt raise; RH -4% after earnings, energy and metals tradind lower, CROX -3% after dg

Gapping up
In reaction to strong earnings/guidance: GRO +19.4%, JDSU +14%, (reaffirms; to Separate into Two Industry-Leading Public Companies), LULU +13.6%, SIGM +10%, LFVN +8%, WTSL +5.9%, MBUU +5.1%, BRC +3.1%, RSH +2.2%

M&A news: RAX +0.9% (cont M&A spec)

Other news: IMRS +19.7% (neurosurgical HFD rocker arm receives FDA clearance), DGLY +12.8% (to introduce ‘Bullet Camera’ option for FirstVU HD body camera system at IACP conference), LAND +7.7% (announces REIT Election), GOGO +5.4% (Gogo and T-Mobile (TMUS) to deliver free in-flight texting and voicemail to T-Mobile customers), RXII +4.5% (presented an update on the company’s dermatology and ophthalmology franchises), PT +3.8% (still checking), FNSR +3.6% (following JDSU news/guidance), GPRO +3.3% (favorable commentary on Wednesday’s Mad Money), SOL +2.1% (to supply 10MW DCR solar modules to Utility-Scale project in India), POWR +1.9% (disclosed it acquired the electrical contracting business of Apex Controls), MDVN +1.4% (FDA approves new indication for the use of XTANDI (enzalutamide) capsules for patients with metastatic castration-resistant prostate cancer), MBLY +1.4% (still checking), EXXI +1.2% (Energy XXI late spike attributed to speculation of Gulf of Mexico asset sale), GTAT +1.2% (modestly rebounding), EMC +1.2% (reports of VMW stake sale), TWX +0.9% (does not have plans for HBO spin off, ‘seriously’ looked at Fox (FOXA) offer, CEO said, according to reports)

Analyst comments: GPRO +3.3% (target raised to $70 from $42 at Citigroup), NES +2% (initiated with a Buy at Stifel), SEAS +1.5% (upgraded to Outperform from Neutral at Macquarie), PBR +1.3% (initiated with an Outperform at Cowen), TS +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley), TCAP +0.7% (upgraded to Outperform from Market Perform at Wells Fargo), JLL +0.6% (upgraded to Overweight from Neutral at JP Morgan), GDP +0.6% (initiated with an Outperform at Cowen)

Gapping down
In reaction to disappointing earnings/guidance: EOPN -28.6%, (updates guidance; announces that three customers will not be renewing contracts; names new head of sales organization ), SYMX -22.9%, DLIA -13%, FIVE -5%, RH -3.8%

Select China related names showing weakness: CAAS -8.8%, CSUN -4.7%, CGA -4.5%, MY -4.5%, VIPS -2%

Select metals/mining stocks trading lower: HMY -2.6%, MT -1.4%, SLV -1.2%, FCX -1.2%, SLW -1.1%, GOLD -0.9%, GG -0.8%, ABX -0.7%

Select oil/gas related names showing early weakness: E -2.4%, RIG -1.6%, BHP -1.6%, SSL -1.6%, STO -1.3%, TOT -1.2%

Other news: INVE -17.4% (announces proposed stock offering ), ASTM -4.4% (announces pricing of public offering of 13,725,490 shares of Common Stock at $2.55/share), NETE -3.7% (following 100%+ move higher yesterday). NBR -3.6% (hearing Activist investor may be selling shares, according to article), TEF -1.9% (still checking), TWTR -1.6% (announces $650 mln convertible unsecured senior note offering; announces amendment to revolving credit agreement)

Analyst comments: CROX -3.7% (downgraded to Neutral from Buy at Buckingham Research), M -1.8% (downgraded to Neutral from Buy at Sterne Agee)

2014

Сен
10

SPY топчется на месте

Ближайший уровень поддержки по SPY – 199.25 уровень сопротивления – 199.75

analytics-10-09-2014

THC продажа ниже 61

BITA покупка при удержании 82

NPSP продажа от 30

Gapping up/down: PANW +5% after earnings, CLF +2% on amended credit facility, TWTR +3% after upgrade; KKD -5% after earnings, AU -12% on restructuring announcement, GTAT -6% on dg at GS

Gapping up
In reaction to strong earnings/guidance: MNDL +10.2%, LMNR +8.1%, DIOD +6.8%, PANW +5.3%, LE +5%, UNIS +4.6%, PPHM +3.2%, PDLI +3.1%, SIRI +1.1%, IHT +1%, SAIC +0.5%.

M&A news: IMPV +2.8% (Imperva, TIBX, TDC among possible takeover targets by HP (HPQ), according to reports), EXPR +1.2% (Barron’s mentions name as M&A target), FDO +0.3% (Dollar General (DG) commences cash tender offer to acquire FDO at $80 per share).

Select EU bell weather names showing strength: BP +1.7%, ING +1.2%, DB +0.9%, RDS.A +0.9%, ALU +0.6%.

Select Biotech stocks trading higher: MNOV +13.3%, NPSP +13% (following FDA briefing docs), TKMR +3.2%, SPPI +2.4%, ACHN +1%.

Other news: DRL +12.4% (announces the sale of ~$430 mln in assets), PVCT +7.5% (still checking), BDBD +6.8% (favorable commentary on Tuesday’s Mad Money), SUPN +6.2% (Orchard Hill Capital Management files amended 13D; request that the Board hires a strategic advisor to consider selling the Company), BWEN +4.1% (announced $14 million in new tower orders from a U.S. wind turbine manufacturer), RADA +3.9% (cont momentum), SUNE +3.6% (Google (GOOG) executes $145 million investment in SunEdison and TerraForm Power’s (TERP) largest solar plant in North America), GPRO +3% (still checking), CLF +1.8% (amended revolving credit facility to allow for $200 mln share repurchase program), FEYE +1.5% (in sympathy with PANW earnings), LTM +1.2% (favorable commentary on Tuesday’s Mad Money), TFSL +1.1% (authorizes the purchase of up to 10,000,000 shares of the Company’s outstanding common stock), THOR +1.1% (announced start of Heartmate III U.S. clinical trial) CRM +1% (signs agreement to establish new european data centre in France; selects Interxion (INXN) as service provider), HAIN +1% (favorable commentary on Tuesday’s Mad Money), TSL +1% (to supply 70MW high efficiency modules to a large-scale solar power project in Chile), KFRC +1% (announces increase to board share buyback authorization by $70 mln).

Analyst comments: TWTR +2.7% (upgraded to Buy from Neutral at UBS), LB +0.9% (upgraded to Outperform from Neutral at Credit Suisse), COH +0.8% (upgraded to Overweight from Neutral at Atlantic Equities), TPLM +0.8% (upgraded to Buy from Accumulate at KLR Group)

Gapping down
In reaction to disappointing earnings/guidance: MGCD -9.7%, KKD -5.2%, URBN -2%, (Thus far during the third quarter of fiscal 2015, comparable Retail segment net sales are low single-digit negative), CBSO -1.8%, CRDS -1.7%, MANU -0.7%.

Other news: AU -11.9% (to explore the possibility of restructuring co into simpler and more focused entities), RSH -10.6% (cont weakness following Wedbush target cut to $0), AHH -5.7% (announces public offering of 5 mln shares of common stock), WBAI -5.4% (Muddy waters follow up from Value Walk), ACT -2.8% ( negative vote from the FDA’s Cardiovascular and Renal Drugs Advisory Committee regarding NDA for nebivolol/valsartan for the treatment of hypertension), SCOK -2.8% (modestly pulling back after yesterday’s advance), AVB -2.4% (announces offering of 4.5 mln shares of common stock), GFI -1.8% (may be in sympathy with AU), EQY -1.6% (announced 3.825 mln share public offering of common stock), STM -1.5% (potentially related to Apple (AAPL) event), TI -1.4% (América Movil (AMX) and Telefonica (TEF) among cos that are close to bid for Telecom Italia’s (TI) Brazil operations, according to reports), ARMH -1.1% (potentially related to Apple (AAPL) event).

Analyst comments: GTAT -6.4% (downgraded to Neutral from Buy at Goldman), BYD -3.4% (downgraded to Equal-Weight from Overweight at Morgan Stanley), MBLY -2.8% (downgraded to Hold from Buy at Deutsche Bank on valuation), EBAY -1.3% (downgraded to Neutral from Overweight at Piper Jaffray), SAVE -1.2% (downgraded to Mkt Perform from Outperform at Cowen), TIF -0.8% (downgraded to Neutral from Outperform at Credit Suisse), AAPL -0.6% (downgraded to Sector Perform from Outperform at Pacific Crest).

2014

Сен
9

SPY понизился на премаркете

Ближайший уровень поддержки по SPY – 200.25 уровень сопротивления – 200.90

analytics-09-09-2014

CMGE продажа от 28.50

MSI продажа от 61

Gapping up/down: BURL +6% and CASY +4% after earnings/guidance, BNNY and IPAS +37% on M&A news, BNNY peers trading higher, MZOR +7% on CFDA approval, THLD +15% on initiation; FRAN -12%, TITN -11%, and FCEL -10% after earnings, POT -1% after dg

Gapping up
In reaction to strong earnings/guidance: BURL +6.1%, CASY +4.1%, TPLM +3.4%, KFY +3%, HELI +2.2%, HDS +1.9%, CTLT +1.1%.

M&A news:BNNY +37.4% (to be acquired by General Mills (GIS) for $46 per share in cash), IPAS +36.8% (to explore strategic alternatives), GFIG +7.2% (BGC Partners (BGCP) announces intent to commence all cash tender offer to acquire GFI Group Shares for $5.25 Per Share).

Select BNNY peers showing strength: WWAV +5.5%, BDBD +4.5%, HAIN +3.8%.

Select Mad Money mentions trading higher: ATK +2%, NFLX +1.6%, LMT +1.1%, RTN +0.9%, SKX +0.5%.

Other news: MZOR +6.8% (receives China CFDA approval for its Renaissance Systems), IDTI +4.8% (working closely with Intel (INTC) on the development of wireless charging solutions), NVFY +3.8% (announces purchase order fulfilled with IKEA China), STKL +3.6% (will further expand its Modesto, California aseptic processing and packaging operation), GTAT +3.1% (ahead of Apple’s product event — speculation as supplier), HSOL +2.6% (signs its second supply agreement with Baotou Shansheng New Energy for delivery of 50 MW of HSOL’s PV modules), PRTS +2.2% (named Michael Yoshida Interim Chief Financial Officer; co has initiated a search for a new CFO), ABB +2.1% (announces $4 bln share repurchase), SGMS +1.9% (awarded three-year instant game contract extension with Colorado lottery), ADXS +1.5% (announces completion of an End-of-Phase 2 Meeting with the FDA for its lead Lm-LLO cancer immunotherapy), GLYC +1.1% (announced that data from preclinical studies demonstrating the in vivo efficacy of GMI-1051 will be presented), IMMR +1% (following late move higher on increased volume), MITK +1% (announced that it has agreed to end all pending litigation with Top Image Systems (TISA) andTIS America), JCP +1% (subsidiary commences underwritten public offering of $350 mln aggregate principal amount of senior unsecured notes), LPCN +0.9% (announces first patient dosed in Phase 1 study in pregnant women of LPCN 1107, potentially the first oral product for the prevention of preterm birth), AAPL +0.7% (trading higher in advance of product event).

Analyst comments: THLD +15% (initiated with a Buy at Cantor Fitzgerald), CTIC +9.7% (initiated with a Overweight at Piper Jaffray), ECYT +5.5% (initiated with a Buy at Cantor Fitzgerald), CEMP +4.2% (receives $10 mln milestone payment from Toyama Chemical Co), MACK +3.5% (initiated with a Buy at Cantor Fitzgerald ), MBLY +3.4% (hearing positive Morgan Stanley comments as catalyst), SYF +3.2% (initiated with a Overweight at JP Morgan and Morgan Stanley, among others), GCA +2.8% (upgraded to Buy at Stifel following MGAM purchase), LYG +2.3% (upgraded to Overweight from Neutral at HSBC Securities), MT +1.9% (upgraded to Outperform from Neutral at Credit Suisse), VRTU +1.7% (upgraded to Overweight from Neutral at JP Morgan), BCS +1.6% (upgraded to Overweight from Neutral at HSBC Securities), MDVN +1.4% (upgraded to Outperform from Mkt Perform at Bernstein), AMRI +1.3% (initiated with a Overweight at JP Morgan), DHI +1.2% (upgraded to Overweight from Neutral at JP Morgan)

Gapping down
In reaction to disappointing earnings/guidance: FRAN -11.7%, TITN -10.7%, FCEL -10.5%, PBY -7.1%, CNSI -5%, FUEL -2.4%, (announces CFO transition and reaffirms prior guidance for the 3Q14 and FY14 ), PTN -1%.

Other news: RADA -5.5% (following 130%+ surge higher following intraday earnings release), AVP -4.1% (announced resignation of CFO Kimberly Ross; Robert Loughran appointed acting CFO effective October 2, 2014), PF -3.7% (announced secondary offering of 15 mln shares of common stock by selling shareholders), DOC -2.6% (announced public offering of 9 mln shares of common stock; announces over $300 mln of commitments for new unsecured revolving credit facility), BKD -1.7% (prices public offering of 8,955,223 shares of Common Stock at $33.50/share), TNET -1.3% (announced commencement of secondary public offering of 10,500,000 shares by stockholders), AKS -1.3% (still checking), WBAI -0.9% (late weakness on cautious Muddy Waters mention).

Analyst comments: LUV -1.1% (initiated with a Neutral at Credit Suisse), POT -1% (downgraded to Underperform from Mkt Perform at Cowen), MOS -0.8% (downgraded to Sector Perform from Outperform at RBC Capital Mkts), JBLU -0.7% (initiated with a Underperform at Credit Suisse), CVX -0.7% (downgraded to Underperform from Neutral at BofA/Merrill).

Лучшие посты месяца

Комментарии

Самое интересное

Группа Вконтакте

Партнеры

Меню: